Artrya (ASX:AYA) secured a three-year commercial agreement with Sonic Healthcare's (ASX:SHL) radiology division for the use of Salix Coronary Anatomy platform for coronary artery disease assessment at the point of care, according to a Wednesday Australian bourse filing.
The contract will generate revenue through a software-as-a-service subscription model and the first revenue is expected in the fiscal fourth quarter, the filing said.
Salix will be integrated into all Sonic Healthcare radiology centers that perform coronary computed tomography angiography scans for coronary heart disease detection, per the filing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。